National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
IN THIS ISSUE
An NCI Perspective on Epidemiology

Epidemiology in a Nutshell

Animation/Video

Audio Clips

Photos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
 
    View All Issues  

MEDIA RESOURCES
Noticias En Español

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page
BenchMarks
------
VOLUME 2, ISSUE 7
------
Audio

TRANSCRIPT: Audio clip from an interview about Epidemiology with Robert Hoover, M.D., Sc.D, NCI:
Q: Are there any fundamental differences in design between epidemiological studies focused on genetic factors and those concerned with environmental factors?


Dr. Hoover: For the most part, the methods in human populations are quite similar. There are some specific methods that are different. For example, family studies are used to identify high penetrance genes-the genes that are responsible for familial cancers. But, these kinds of studies are not very productive for studying environmental exposure because most families tend to have the same environmental exposures. Outside of that, trying to evaluate the impact of natural genetic variation in the population on cancer risk is very similar to looking at environmental exposures. It's essentially another exposure--you are exposed to a particular version of a gene.

One difference, however, is a difference in scale. In environmental studies, we worry about confounding exposures. So, if you're investigating coffee drinking, you have to control for the effects of tobacco because they usually correlate. But, there are usually a limited number of confounding factors that you know about or that you can assess. With the new genetic technology, there is a new possibility that if you're interested in a particular gene, there may be thousands of others whose effects you may be called upon to control for. This does serve up a kind of challenge of scale that we haven't seen before. In general, however, the principles are largely similar and transferable.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov